PolyProx Therapeutics
Latest round
- Seed
Last raised
- Jan 2020
Total raised
- $5.6M
Investors
- 4
About PolyProx Therapeutics
Established in 2018 and based in Cambridge, UK, PolyProx Therapeutics is a biopharmaceutical firm that develops Polyproxin™ molecules for the treatment of cancer and neurodegenerative disorders through targeted degradation and removal of abnormal proteins.
Who invested in PolyProx Therapeutics
4 investors across 2 rounds
See all investors in PolyProx Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PolyProx Therapeutics
Who invested in PolyProx Therapeutics?
PolyProx Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PolyProx Therapeutics raised?
PolyProx Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did PolyProx Therapeutics last raise money?
PolyProx Therapeutics's most recent round on record is a Seed, in Jan 2020.
What does PolyProx Therapeutics do?
Established in 2018 and based in Cambridge, UK, PolyProx Therapeutics is a biopharmaceutical firm that develops Polyproxin™ molecules for the treatment of cancer and neurodegenerative disorders through targeted degradation and removal of abnormal proteins.
Where is PolyProx Therapeutics headquartered?
PolyProx Therapeutics is headquartered in Cambridge, UK.
Which VCs invest in companies like PolyProx Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at PolyProx Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like PolyProx Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.